FISH detection probe for detecting EB virus of infectious mononucleosis patent
A technology of EB virus and detection probe, which is applied in the field of medical diagnosis and can solve problems such as false positives and easy contamination
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0046] FISH technology is currently a common method for clinical detection of genes and viral DNA, which is very intuitive and has high sensitivity and specificity. However, there is no supply of finished probes for detecting EBV at home and abroad, and previous reports are often limited to basic research. Therefore, it is particularly necessary to develop FISH EBV probes that can be generally applied to clinical practice. In our previous work, the virus supernatant of the P3hr-1 cell line that produced EBV was used to concentrate EBV through a column virus purification column, and the DNA of EBV was extracted by a DNA extraction kit. Design DNA primers specific to the BaMH segment of EBV to amplify this segment of DNA to obtain a 3267bp DNA fragment, and send it to Nanjing GenScript Company for sequencing confirmation. FISH probes were successfully developed through related steps. In order to verify the clinical application value of this probe, we first detected the express...
experiment example
[0101] The inventor used the self-developed FISH probe to detect 38 leaflet patients, and compared it with conventional detection methods. The specific results are as follows. It can be seen from the table that the positive rate of leaflet patients detected by FISH method is significantly higher than that of conventional heterophile agglutination test, EBV-VCA-IgM, and also higher than PCR method, which is currently considered the most sensitive clinically. Therefore, it has a broad practical prospect to promote this method in clinic.
[0102]
[0103]
[0104] Note: In the above table, FISH technology was used to detect 38 cases of leaflet patients, and the positive rate was 97.4%, which was obviously higher than that of heterophile agglutination, EBV-VCA antibody and PCR positive rate by immunoassay. Moreover, it has certain differential diagnosis significance for the EBV load that can be used to detect light and heavy leaflets.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com